Asset Allocation & Fund Positioning, Copley Fund Research

Steven Holden

Asset Allocation & Fund Positioning

Copley Fund Research

Copley Fund Research provide research and data on asset allocation among Global and Emerging Market equity funds.  The analysis details absolute and relative positioning across countries, sectors and industries together with highly granular data on single stock and single fund allocations.  The data is updated monthly with time series going back to January 2011.

Global Research - Analysis of 165 prominent Global equity funds, combined AUM $335bn
GEM Research - Analysis of 127 prominent global EM equity funds, combined AUM $250bn

Asset Allocation - Global and GEM Equity

Cross Asset Strategy

<p>Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with the percentage of EM funds with exposure dropping by 11% and average holding weights down by 1.4%. However, in recent months there has been evidence the downward trend is meeting resistance. Ownership statistics are above the lows seen at the start of the year and in certain countries are on an upward trend. We take a look at the sector in detail to determine current positioning and what is driving the reversal.</p>

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with the percentage of EM funds with exposure dropping by 11% and average holding weights down by 1.4%. However, in recent months there has been evidence the downward trend is meeting resistance. Ownership statistics are above the lows seen at the start of the year and in certain countries are on an upward trend. We take a look at the sector in detail to determine current positioning and what is driving the reversal.

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

MSCI Emerging Markets Index / Technical Analysis

<p>Despite recent deterioration, technical price and relative strength support levels continue to hold, and uptrends remain intact, for the MSCI EM index. Until this changes, we continue to view recent weakness as a buying opportunity.  The attached report is a bottoms up summary of technically attractive setups across all emerging markets and sectors.  Our screen parameters included stocks hitting a 26-week relative strength high, with a greater than 500 million market cap. Taiwan, China, and…</p>

Despite recent deterioration, technical price and relative strength support levels continue to hold, and uptrends remain intact, for the MSCI EM index. Until this changes, we continue to view recent weakness as a buying opportunity.  The attached report is a bottoms up summary of technically attractive setups across all emerging markets and sectors.  Our screen parameters included stocks hitting a 26-week relative strength high, with a greater than 500 million market cap. Taiwan, China, and…

Taiwan

Ginko International Company Ltd. develops and manufactures contact lenses and contact lens care products. The Company's main products include conventional contact lenses, disposable contact lenses and lens care products, and mainland China is its main market for sales.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Ginko International (8406 TT)

EM Health Care: Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Steven Holden

EM: Technical Leadership Charts & Screen

Despite recent deterioration, technical price and relative strength support levels continue to hold, and uptrends remain intact, for the MSCI EM...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)